Item 9 Labs Corp. Announces Second Quarter FY 2022 Financial Results with Revenue Growth of 9% to $6.6 Million – PR Newswire

National Unity Rd. Dispensary Franchise Footprint Expands into Three New States Cultivation, Production and Processing Expansion in Nevada Nears Completion with Phase One of Arizona Development also on Track Management to Host Conference Call and Webcast to Discuss Key Operational and Financial Highlights Today at 4:30 p.m. ET

PHOENIX, May 16, 2022 /PRNewswire/ — Item 9 Labs Corp. (OTCQX: INLB) (the “Company”)—a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products—today reported its fiscal second quarter operating and financial results for the three months ended March 31, 2022.

“Last year, our team focused on strengthening our position for future growth, both locally in Arizona and nationally across the U.S.,” said Item 9 Labs Corp.’s Chief Executive Officer, Andrew Bowden. “The momentum we’ve achieved over the past quarter demonstrates the power of this foundation and gives a glimpse into what’s ahead for our national growth and product excellence.”

Key Business Highlights During Q2 FY2022 (January 1 – March 31, 2022)

Bowden continued, “Focusing on execution sums up our plan for 2022 as we continue our mission to keep the door to cannabis entrepreneurship open to the everyday entrepreneur and bring more high-quality, alternative medicine to consumers nationwide. As large equity

Read More Here...